Epithelial Cell Proliferation Contributes to Airway Remodeling in Severe Asthma

Despite long-term therapy with corticosteroids, patients with severe asthma develop irreversible airway obstruction. To evaluate if there are structural and functional differences in the airway epithelium in severe asthma associated with airway remodeling. In bronchial biopsies from 21 normal subjec...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 176; no. 2; pp. 138 - 145
Main Authors Cohen, Lance, E, Xueping, Tarsi, Jaime, Ramkumar, Thiruvamoor, Horiuchi, Todd K, Cochran, Rebecca, DeMartino, Steve, Schechtman, Kenneth B, Hussain, Iftikhar, Holtzman, Michael J, Castro, Mario, and NHLBI Severe Asthma Research Program (SARP)
Format Journal Article
LanguageEnglish
Published New York, NY Am Thoracic Soc 15.07.2007
American Lung Association
American Thoracic Society
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Despite long-term therapy with corticosteroids, patients with severe asthma develop irreversible airway obstruction. To evaluate if there are structural and functional differences in the airway epithelium in severe asthma associated with airway remodeling. In bronchial biopsies from 21 normal subjects, 11 subjects with chronic bronchitis, 9 subjects with mild asthma, and 31 subjects with severe asthma, we evaluated epithelial cell morphology: epithelial thickness, lamina reticularis (LR) thickness, and epithelial desquamation. Levels of retinoblastoma protein (Rb), Ki67, and Bcl-2 were measured, reflecting cellular proliferation and death. Terminal deoxynucleotidyl-mediated dUTP nick end labeling (TUNEL) was used to study cellular apoptosis. Airway epithelial and LR thickness was greater in subjects with severe asthma compared with those with mild asthma, normal subjects, and diseased control subjects (p=0.009 and 0.033, respectively). There was no significant difference in epithelial desquamation between groups. Active, hypophosphorylated Rb expression was decreased (p=0.002) and Ki67 was increased (p<0.01) in the epithelium of subjects with severe asthma as compared with normal subjects, indicating increased cellular proliferation. Bcl-2 expression was decreased (p<0.001), indicating decreased cell death suppression. There was a greater level of apoptotic activity in the airway biopsy in subjects with severe asthma as compared with the normal subjects using the TUNEL assay (p=0.002), suggesting increased cell death. In subjects with severe asthma, as compared with subjects with mild asthma, normal subjects, and diseased control subjects, we found novel evidence of increased cellular proliferation in the airway contributing to a thickened epithelium and LR. These changes may contribute to the progressive decline in lung function and airway remodeling in patients with severe asthma.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org
A complete list of SARP members may be found before the reference section.
Originally Published in Press as DOI: 10.1164/rccm.200607-1062OC on April 26, 2007
Conflict of Interest Statement: L.C. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. X.E. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. J.T. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. T.R. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. T.K.H. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. R.C. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. S.D. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. K.B.S. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. I.H. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. M.J.H. was the principal investigator on a research grant from Roche for $35,000 per year from 2001 to 2004. M.C. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript.
Correspondence and requests for reprints should be addressed to Mario Castro, M.D., M.P.H., Washington University School of Medicine, Campus Box 8052, 660 South Euclid Avenue, St. Louis, MO 63110-1093. E-mail: castrom@wustl.edu
Supported by NIH grants HL69149 and M01RR00036 (M.C.).
ISSN:1073-449X
1535-4970
DOI:10.1164/rccm.200607-1062OC